Home
About
About Us
Openings at CURIN
Our Faculty
Analytics
Patents
Consultancy
Sponsored Research
International Research Collaborations
Publications
Journals
Conferences
Books/Book Chapters
Doctoral Programs
Approved Supervisors
PhD Awarded
PhD Scholars
Research Collaborations
Research Facilities
Central Instrumentation Facilities
Fabrication Facility
Animal House
Media Laboratory / Studios
Research & Statistical Database
Centres of Excellence
Policies
Recognitions
Research Committee
News & Events
News
Events
Video Gallery
Excellence Awards
Rise Reports
Res Novae
Tech-Connect
CURIN Day
Contact Us
TYPE TO SEARCH
X
Home
About
About Us
Openings at CURIN
Our Faculty
Analytics
Patents
Consultancy
Sponsored Research
International Research Collaborations
Publications
Journals
Conferences
Books/Book Chapters
Doctoral Programs
Approved Supervisors
PhD Awarded
PhD Scholars
Research Collaborations
Research Facilities
Central Instrumentation Facilities
Fabrication Facility
Animal House
Media Laboratory / Studios
Research & Statistical Database
Centres of Excellence
Policies
Recognitions
Research Committee
News & Events
News
Events
Video Gallery
Excellence Awards
Rise Reports
Res Novae
Tech-Connect
CURIN Day
Contact Us
“A COMPOSITION FOR PHARMACOLOGICAL POSTCONDITIONING OF CEREBRAL ISCHEMIA AND REPERFUSION-INDUCED INJURY COMPRISING 3-CYCLOPENTYLOXY-N-(3,5-DICHLOROPYRIDIN-4-YL)- 4-METHOXYBENZAMIDE”
Inventors
THAKUR GURJEET SINGH, AMARJOT KAUR, ARVIND SHARMA, HEENA KHAN
Patent File Number - 202211038655 Patent File Date - 05/07/2022